Connecticut General Life Insurance Company v. Ogbebor

CourtDistrict Court, D. Connecticut
DecidedSeptember 6, 2022
Docket3:21-cv-00954
StatusUnknown

This text of Connecticut General Life Insurance Company v. Ogbebor (Connecticut General Life Insurance Company v. Ogbebor) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Connecticut General Life Insurance Company v. Ogbebor, (D. Conn. 2022).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

CONNECTICUT GENERAL LIFE INSURANCE COMPANY and CIGNA HEALTH AND LIFE INSURANCE COMPANY, Plaintiffs, No. 3:21-cv-00954 (JAM)

v. MIKE OGBEBOR and STAFFORD RENAL LLC, Defendants.

ORDER GRANTING MOTION FOR DEFAULT JUDGMENT This case concerns an insurance company seeking to recover payments it made to an unlicensed medical provider who submitted fabricated claims for dialysis treatments. The defendants, Stafford Renal LLC (Stafford) and its owner Mike Ogbebor, received insurance payments from the plaintiffs, Connecticut General Life Insurance Company and Cigna Health and Life Insurance Company (collectively, “Cigna”), for dialysis Stafford claims to have administered to two Cigna plan members. Cigna claims that Stafford was not licensed to provide and in fact did not provide these dialysis treatments. After Cigna filed its complaint in this action, Ogbebor submitted an answer on behalf of both defendants. I struck this answer with respect to Stafford because Ogbebor as a non-lawyer could not represent in court a limited liability company such as Stafford. Cigna then moved for a default entry against Stafford, which I granted based on Stafford’s failure to appear or respond. As for Ogbebor, he has failed to object or respond in any way to Cigna’s discovery requests. Ogbebor has also failed to respond to a motion to compel discovery, despite the Court’s discovery order warning him that such failure might result in sanctions including default judgment. Cigna now moves for default judgment against both Stafford and Ogbebor. I will grant the motions for default judgment. Because Stafford has altogether failed to respond and Ogbebor has responded but willfully failed to comply with his discovery obligations, I accept the allegations in Cigna’s complaint as true with respect to both defendants. On those facts, Stafford and Ogbebor are liable to Cigna for submitting fabricated claims on

behalf of an unlicensed provider. For the reasons that follow, I conclude that Cigna is entitled to a declaratory judgment that it has no obligation to pay any claims submitted by Stafford for dialysis services, to actual damages from both defendants for the payments Cigna already made, and to treble damages for civil theft. BACKGROUND The following facts are taken from Cigna’s complaint. Cigna is a health services company whose services include the administration of employee health and welfare benefit plans.1 Cigna administers these plans for beneficiaries under the Employee Retirement Income Security Act of 1974 (ERISA), 29 U.S.C. §§ 1001 et seq.2

Ogbebor formed Stafford as a limited liability company organized under Texas law, and served as its owner, principal, and manager.3 Stafford held itself out to be a treatment facility for end stage renal disorder (ESRD).4 But Stafford did not have an ESRD license.5 In fact, Ogbebor was associated with another company known as Stafford Dialysis Renal, Inc., which operated a licensed ESRD facility.6 That license, however, expired in November 2016.7

1 Doc. #1 at 1 (¶ 2). 2 Id. at 5-6 (¶¶ 26, 35). 3 Id. at 2-3 (¶¶ 4, 8, 11). 4 Id. at 3 (¶ 10). 5 Id. at 6 (¶ 40). 6 Id. at 2 (¶ 3). 7 Id. at 4 (¶ 20). In 2017, Ogbebor submitted bills to Cigna for ESRD treatments purportedly provided by Stafford.8 In May 2020, Cigna initiated an investigation into Stafford due to its billing of a drug used in ESRD treatment at significantly inflated prices.9 As part of its investigation, Cigna learned that Stafford did not have an ESRD license.10 Stafford was therefore operating in

violation of Texas licensing requirements, which provide that “a person may not operate an end stage renal disease facility without a license issued under this chapter.” Tex. Health & Safety Code § 251.011. Despite its unlicensed status, Stafford submitted and received claims totaling $4,790,461.65 from Cigna for supposed ESRD services to two Cigna members.11 When Cigna asked Stafford and Ogbebor to show proof of proper licensing, they failed to do so.12 Cigna then reduced or denied payment on other claims submitted by Stafford.13 The defendants also allegedly fabricated a majority of the treatments for which they sought and obtained reimbursements from Cigna. Despite sending medical record requests and repeated follow-up inquiries as part of its investigation, Cigna received records for only 69 of the 892 dates of service billed for one member, and no records for treatment of a second member.14

The 69 records Ogbebor and Stafford provided contained duplicate information suggesting that the records had been “cloned.”15 Further, although Stafford supposedly provided services to one plan member on nearly every day from April 2018 through June 2020, Cigna learned from the member and confirmed with Medicare that she did not begin treatment until January 2019.16

8 Ibid. (¶ 21). 9 Ibid. (¶ 22). 10 Id. at 6 (¶ 40). 11 Id. at 4-6 (¶¶ 27-28, 36). 12 Id. at 6 (¶¶ 37, 39). 13 Id. at 2 (¶ 6). 14 Id. at 4, 6 (¶¶ 23-24, 37-39). 15 Id. at 6 (¶ 38). 16 Id. at 5 (¶¶ 25, 31-32). Cigna brought this action against Ogbebor and Stafford in July 2021, alleging eight counts arising from the fraudulent submission of claims for ESRD treatments.17 First, Cigna seeks a declaratory judgment against Stafford stating that it has no liability for any unpaid claims. Second, Cigna seeks damages from both defendants on six counts: (I) for recoupment

under ERISA § 502(a)(3); (II) for fraudulent misrepresentation; (III) for negligent misrepresentation; (IV) for violating the Connecticut Unfair Trade Practices Act (“CUTPA”), Conn. Gen. Stat., §§ 42-110b et seq.; (V) for violating the Connecticut Health Insurance Fraud Act (“CHIFA”), Conn. Gen. Stat. §§ 53-440 et. seq.; and (VI) for civil theft, Conn. Gen. Stat. § 52-564. Lastly, Cigna seeks to pierce the corporate veil and hold Ogbebor personally liable for using Stafford as an illegitimate business entity to commit insurance fraud. Stafford has yet to appear or file any responsive pleading in this action. Following an entry of default against Stafford in November 2021, Cigna moved for a default judgment.18 Ogbebor has filed an answer with affirmative defenses.19 But he has failed to respond to Cigna’s interrogatories, requests for production, and requests for admission, despite follow-up communications from Cigna’s counsel, a motion to compel production, and a discovery order.20

The discovery Cigna seeks includes medical records documenting the ESRD treatments at issue and Stafford’s license to perform those services; Ogbebor’s role in Stafford’s ownership, management and operations; Ogbebor’s role in submitting claims to Cigna; financial information related to Stafford’s receipt of insurance payments; and Ogbebor’s legal and criminal record for

17 Id. at 7-16 (¶¶ 47-106). 18 Doc. #24. 19 Doc. #32. 20 Doc. #29-1 at 1-2 (¶¶ 4-11) (declaration of counsel for Cigna); Doc. #29 (motion to compel discovery); Doc. #30 (order requiring Ogbebor to file any objection or other response to the motion to compel discovery and advising him that “a failure to respond to the motion to compel discovery may result in the Court’s entry of sanctions including default judgment”). past fraud.21 It is apparent that without discovery on these subjects, Cigna cannot prove that Ogbebor was personally responsible for submitting the claims at issue or that he was aware of their fraudulent nature.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brown v. Sandimo Materials
250 F.3d 120 (Second Circuit, 2001)
Guggenheim Capital, LLC v. Birnbaum
722 F.3d 444 (Second Circuit, 2013)
Securities & Exchange Commission v. Razmilovic
738 F.3d 14 (Second Circuit, 2013)
Ramirez v. Health Net of the Northeast, Inc.
938 A.2d 576 (Supreme Court of Connecticut, 2008)
ALV Events International v. Johnson
821 F. Supp. 2d 489 (D. Connecticut, 2010)
City of New York v. Mickalis Pawn Shop, LLC
645 F.3d 114 (Second Circuit, 2011)
Michael Dodd and 3D Global Solutions, Inc. v. Brian J. Savino
426 S.W.3d 275 (Court of Appeals of Texas, 2014)
Chevron Corp. v. Donziger
833 F.3d 74 (Second Circuit, 2016)
Richard Nugent and CAO, Inc. v. the Estate of Janie Baker Ellickson
543 S.W.3d 243 (Court of Appeals of Texas, 2018)
Onofrio v. Mineri
207 Conn. App. 630 (Connecticut Appellate Court, 2021)
Bentley v. Greensky Trade Credit, LLC
156 F. Supp. 3d 274 (D. Connecticut, 2015)
Roberts v. Bennaceur
658 F. App'x 611 (Second Circuit, 2016)
Johnson v. Walden University, Inc.
839 F. Supp. 2d 518 (D. Connecticut, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
Connecticut General Life Insurance Company v. Ogbebor, Counsel Stack Legal Research, https://law.counselstack.com/opinion/connecticut-general-life-insurance-company-v-ogbebor-ctd-2022.